Eveline Mutsaers – Page 4

BOM Capital invests in Holland Venture

We advised BOM Capital with its investment in Holland Venture, an investment fund focusing on promising Dutch companies operating in the Healthcare and Technology sectors.

Niels_Admin1 August 2016

Eveline Mutsaers Track Record Venture Capital

Gilde and INKEF invest in NightBalance

We advised Gilde Healthcare Partners in the Series B financing of NightBalance. The round was led by INKEF Capital and Gilde. NightBalance developed and introduced the Sleep Position Trainer to prevent positional obstructive sleep apnea. The Series B financing allows NightBalance to intensify and expand commercial efforts in Europe and prepare for the company’s entry into the US market.

Niels_Admin5 July 2016

Eveline Mutsaers M&A Track Record

Sale of Addcomp to Altana

We advised the selling shareholders of Addcomp in the sale of their shares to German chemical company Altana AG. Addcomp develops and manufactures unique polymer additive solutions, enhancing the functional performance of thermoplastic materials, such as anti-fogging, flame retardancy and UV stabilization.

Niels_Admin1 July 2016

Eveline Mutsaers Niels Hofkes Track Record Venture Capital

BOM provides growth financing to Vendinova Group

We advised the Brabantse Ontwikkelings Maatschappij (BOM) for an investment in the Vendinova Group from Nieuwkuijk. Vendinova wants to conquer the (inter)national market with the Soup-Server: the world's first soup dispenser for 100 percent natural, fresh soups.

Niels_Admin4 February 2016

Eveline Mutsaers Lawyers Track Record Venture Capital

BOM Capital invests in Gilde Healthcare

We advised BOM Capital with its investment in Gilde Healthcare IV, an investment fund investing in innovative medical technology companies, digital health and therapeutics in Europe and the US.

Niels_Admin1 February 2016

Eveline Mutsaers Lawyers Track Record Venture Capital

LSP invests in ViCentra

We advised LSP (Life Sciences Partners) with its investment in the Series B financing round of ViCentra, a company developing and commercializing an insulin pump system for diabetes patients. With its Kaleido insulin pump, ViCentra aims to reduce the impact that diabetes can have on daily life. The syndicate, led by LSP with participation from existing investor INKEF, will invest EUR 10 million. The funding will support European commercialization of the Kaleido system and preparations for US market entry.

Niels_Admin20 January 2016

Eveline Mutsaers Track Record Venture Capital

BOM Capital invests in Endeit Capital

We advised BOM Capital with its investment in Endeit Fund II, an investment fund providing growth equity to European internet technology companies.

Niels_Admin1 January 2016

Eveline Mutsaers Lawyers Track Record Venture Capital

Stichting DOEN invests in Zeewaar

We advised Stichting DOEN with its investment in Zeewaar, a company that farms seaweed and produces and sells seaweed products.

Niels_Admin1 January 2016

Eveline Mutsaers Lawyers Track Record Venture Capital

BOM Capital invests in Aglaia Biomedical Ventures

We advised BOM Capital with its investment in Aglaia Oncology Fund II, an investment fund focusing on biomedical companies in the field of oncology.

Niels_Admin1 December 2015

Eveline Mutsaers Lawyers Track Record Venture Capital

Stichting DOEN invests in Nederland Isoleert

We advised Stichting DOEN with its investment in Nederland Isoleert, a company that provides isolation for homes in the Netherlands by way of collective purchasing.

Niels_Admin1 December 2015